6533b870fe1ef96bd12cf126

RESEARCH PRODUCT

Incidence of hepatitis C virus infection in patients with chronic kidney disease on conservative therapy

Carlo GiammarresiMaurizio SoresiL BonoAngelo FerrantelliCarmela ZagarrigoU RotoloAngelo TralongoCalogera TortoriciOnofrio SchillaciGioacchino Li Cavoli

subject

MaleMicrobiology (medical)medicine.medical_specialtyHepatitis C virusPopulationPrevalence of infectionHepacivirusmedicine.disease_causeDialysis patientsRenal DialysisChronic kidney diseaseInternal medicineEpidemiologyHumansMedicineIn patientRenal Insufficiency ChroniceducationSicilyAgedAged 80 and overeducation.field_of_studybusiness.industryIncidencePublic healthIncidence (epidemiology)virus diseasesGeneral MedicineHepatitis C AntibodiesMiddle Agedmedicine.diseaseHepatitis Cdigestive system diseasesHCV infectionEpidemiologic StudiesInfectious DiseasesImmunoglobulin GImmunologyRNA ViralFemalePublic HealthbusinessKidney disease

description

SummaryHepatitis C virus (HCV) infection is a never-ending public health problem. Many studies have investigated the incidence of HCV infection among dialysis patients, but there have only been a few epidemiological studies in renal conservative therapy. We studied 320 subjects with pre-dialysis chronic kidney disease living in Sicily, Italy. The incidence of HCV infection was 6.25%. In Europe, incidence ranges from 0.2% to 3.5%. It appears that the incidence of HCV infection is higher in the studied patient population than in the population as a whole.

https://doi.org/10.1016/j.ijid.2011.04.001